TANG CAPITAL PARTNERS LP 13D and 13G filings for Bellerophon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | Bellerophon Therapeutics, Inc. BLPH |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-1,062,619 (Position Closed) |
Filing |
| 2023-03-17 4:00 pm Purchase |
2023-03-07 | 13G | Bellerophon Therapeutics, Inc. BLPH |
TANG CAPITAL PARTNERS LP | 1,062,619 9.990% |
1,062,619 (New Position) |
Filing |